CSIMarket
 
Chromocell Therapeutics Corporation  (CHRO)
Other Ticker:  
 
 

Chromocell Therapeutics Balance Sheet Annual

CHRO


Select the Financial Report:   Period:   Fiscal Year:




CHRO Balance Sheets
(Annual, GAAP in millions $)

(Dec 31 2023)
2023




ASSETS
Cash & cash equivalent 0.10 - - - -
Cash, Cash Eqvivalents Other - - - - -
Cash & Short-term Investments 0.10 - - - -
Accounts receivable - - - - -
Accounts Receivable, Related Parties, Current - - - - -
Notes, Loans and Financing Receivable, Net, Current AC - - - - -
Inventories - - - - -
Total Current Assets 0.10 - - - -
Equipment/Property/Plant Net - - - - -
Goodwill net - - - - -
Intangible Assets - - - - -
Long-term investments - - - - -
Notes, Loans and Financing Receivable, Net, Noncurrent LO - - - - -
Financial Instruments - - - - -
Tax Assets, Noncurrent - - - - -
Deferred, Prepaid and Other Assets, Noncurrent - - - - -
Discontinued operations, Noncurrent - - - - -
Total Assets 0.10 - - - -
LIABILITIES
Accounts Payable and Accrued Liabilities, Current LI 4.62 - - - -
Accrued Liabilities, Current AC 0.65 - - - -
Financial Instruments - - - - -
Bridge Loan SH 0.32 - - - -
Other Liabilities, Current 0.96 - - - -
Taxes Payable - - - - -
Deferred Revenue, Current DE - - - - -
Discontinued Operation, Liabilities, Current - - - - -
Total Current Liabilities 6.54 - - - -
Long-term debt 0.75 - - - -
Capital Lease and Other - - - - -
Convertible Notes Payable, Noncurrent LO - - - - -
Total Long-term Debt 0.75 - - - -
Financial Instruments, Insurance, Noncurrent - - - - -
Employee Benefit Plans, Noncurrent - - - - -
Deferred Revenue, Noncurrent DE - - - - -
Accrued Income Taxes, Noncurrent - - - - -
Discontinued Operation, Liabilities, Noncurrent - - - - -
Other liabilities, Noncurrent - - - - -
Due To Chromocell Corporation 0.01 - - - -
Total Liabilities 6.54 - - - -
SHAREHOLDER'S EQUITY
Common Stock Value 0.00 - - - -
Additional Paid In Capital Common Stock 7.07 - - - -
Retained Earnings / Accumulated Deficit -13.52 - - - -
Other Equity 0.00 - - - -
Common Stockholder's Equity -6.44 - - - -
Preferred Stockholder's Equity 0.00 - - - -
Noncontrolling interests & other - - - - -
Total Stockholder's Equity -6.44 - - - -
Liabilities & Stockholder's Equity 0.10 - - - -






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com